USPTO trademark

MESYNKRO

AllowedUSPTOWord markClass 5

"MESYNKRO" is a word mark owned by Pfizer Inc., filed at the USPTO on November 10, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

View Pfizer Inc. portfolioGet this data via the API
Official USPTO record
MESYNKRO trademark as filed
As filed with the USPTO
Status
Allowed
Since June 23, 2026
Filed
November 10, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99487710
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns MESYNKRO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Pfizer Inc.

PFE · New York, United States

6,827 trademarks in the portfolioView company

Representative

Heather A. McDonald

Pfizer Inc.

Goods and services

What the mark covers

The products and services MESYNKRO is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Noa e-mailed - sou required from applicant
  2. Official gazette publication confirmation e-mailed
  3. Published for opposition
  4. Notification of notice of publication e-mailed
  5. Approved for pub - principal register
  6. Teas/email correspondence entered
  7. Correspondence received in law office
  8. Teas response to office action received
  9. Notification of non-final action e-mailed
  10. Non-final action e-mailed

5 earlier steps on the official record.

FAQ

About MESYNKRO

Who owns the trademark "MESYNKRO"?

The USPTO trademark "MESYNKRO" (application 99487710) is owned by Pfizer Inc.

What is the status of "MESYNKRO"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull MESYNKRO and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b59-9cf3-710b-81df-45485ddbd798
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b59-9cf3-710b-81df-45485ddbd798",
  "object": "trademark",
  "mark_text": "MESYNKRO",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99487710",
  "filing_date": "2025-11-10",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Pfizer Inc.",
      "entity_id": "ent_019f2853-15ff-713b-878b-ed770179b310"
    }
  ]
}